FDA Inspection 926973 — Central California Blood Center

Central California Blood Center — FEI 2970009

The FDA completed an inspection of Central California Blood Center on May 18, 2015 in Visalia, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 18, 2015
Fiscal Year
2015
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Visalia, CA (United States)